These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24243636)

  • 21. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center.
    Barrande G; Pittino-Lungo M; Coste J; Ponvert D; Bertagna X; Luton JP; Bertherat J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3779-85. PubMed ID: 11061538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
    Bastemir M; Akin F; Yaylali GF
    Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly.
    Barkan AL; Halasz I; Dornfeld KJ; Jaffe CA; Friberg RD; Chandler WF; Sandler HM
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3187-91. PubMed ID: 9329336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excessively high soluble Klotho in patients with acromegaly.
    Sze L; Bernays RL; Zwimpfer C; Wiesli P; Brändle M; Schmid C
    J Intern Med; 2012 Jul; 272(1):93-7. PubMed ID: 22452701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between serum GH and serum IGF-I in acromegaly is gender-specific.
    Parkinson C; Ryder WD; Trainer PJ;
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5240-4. PubMed ID: 11701684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The critical parameters in GH excess.
    Sheppard MC
    J Endocrinol Invest; 2005; 28(5 Suppl):92-5. PubMed ID: 16114283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between GH and IGF-1 during treatment for acromegaly.
    Oldfield EH; Jane JA; Thorner MO; Pledger CL; Sheehan JP; Vance ML
    J Neurosurg; 2017 Jun; 126(6):1959-1966. PubMed ID: 27858572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues.
    Sherlock M; Fernandez-Rodriguez E; Alonso AA; Reulen RC; Ayuk J; Clayton RN; Holder G; Sheppard MC; Bates A; Stewart PM
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1255-63. PubMed ID: 19158203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?
    Cozzi R; Attanasio R; Montini M; Pagani G; Lasio G; Lodrini S; Barausse M; Albizzi M; Dallabonzana D; Pedroncelli AM
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3090-8. PubMed ID: 12843148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly.
    Biermasz NR; van Dulken H; Roelfsema F
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2476-82. PubMed ID: 10902796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocysteine levels in acromegaly patients.
    Hekimsoy Z; Ozmen B; Ulusoy S
    Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum leptin levels in patients with acromegaly before and after correction of hypersomatotropism by trans-sphenoidal surgery.
    Damjanović SS; Petakov MS; Raicević S; Micić D; Marinković J; Dieguez C; Casanueva FF; Popović V
    J Clin Endocrinol Metab; 2000 Jan; 85(1):147-54. PubMed ID: 10634378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy).
    Colao A; Vandeva S; Pivonello R; Grasso LF; Nachev E; Auriemma RS; Kalinov K; Zacharieva S
    Eur J Endocrinol; 2014 Aug; 171(2):263-73. PubMed ID: 24878680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly.
    Jenkins PJ; Bates P; Carson MN; Stewart PM; Wass JA
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1239-45. PubMed ID: 16403824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
    Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
    Kohler S; Tschopp O; Sze L; Neidert M; Bernays RL; Spanaus KS; Wiesli P; Schmid C
    Gen Comp Endocrinol; 2013 Jul; 188():282-7. PubMed ID: 23648743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements.
    Biermasz NR; Dekker FW; Pereira AM; van Thiel SW; Schutte PJ; van Dulken H; Romijn JA; Roelfsema F
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2789-96. PubMed ID: 15181059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing mortality in acromegaly.
    Holdaway IM; Rajasoorya RC; Gamble GD
    J Clin Endocrinol Metab; 2004 Feb; 89(2):667-74. PubMed ID: 14764779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.